DrAnsay Logo
New
G-Runtz
hybrid-indica
THC 32%
CBD 1%

G-Runtz

LIGHV Trials 32/1 GR

No rating yet
Buying fromInfo Icon
Info Icon

This is how we calculate discounts: To ensure you always get the best price, we only display discounts when the next higher offer is significantly more expensive.

5g

IrradiationNo
CountryThailand
ProducerNOVVIA PHARM GmbH

LIGHV Trials 32/1 GR is a Hybrid-indica flower of the strain G-Runtz with a THC level of 32% and a CBD level of 1%. The main terpenes are Limonen, Caryophyllen, Beta-Myrcen.

  • Inflammations
    Very effective
  • Stress
    Very effective
  • Anxiety
    Effective
Also: Parkinson's disease, Reduced appetite, Chronic pain, Depression, Gastrointestinal problems, Immunological disorders, Pain, Sleep disorders

  • Anti-Inflammatory Icon
    Anti-inflammatory
    Very strong
  • Analgesic Icon
    Analgesic
    Weak
  • Antibacterial Icon
    Antibacterial
    Weak
Also: Antifungal, Antioxidant, Mood-enhancing, Pain-relieving, Relaxing, Stress relieving